Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval is a research paper published in JAMA Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: T32 CA009615
NCI NIH HHS
Grant: K08 CA263541
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Fields of Study
MeSH Terms
Keywords